Insights from AACR Shed Light on China’s Innovations: ADC and Bispecific Antibodies Take the Lead Witnessing the Gold Content of Licensing Deals
April 23, 2026 — 16:00 CST
This Data Is Locked!
This area is available only to Subscribers.
If the data at AACR is like a parade showcasing China's innovative drug technology strength, then the surge in BD transactions is a market 'vote'... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals
